By Nicholina Korto
Faryond Limited is proud to reaffirm its commitment to advancing medical infrastructure and long-term sustainability in Africa through our ongoing partnerships with global leaders in cryogenic and medical oxygen technology Auguste Cryogenics, Cryonorm Group, and Ambra Sistemi.
We extend our deepest gratitude to our partner Auguste Cryogenics for delivering a highly impactful and technically robust cryogenic training program.
Hosted at LEKMA Hospital in Ghana, the training was specifically designed for engineers from the Ghana Health Service and RikAir, covering both theoretical foundations and hands-on practical applications of cryogenic tank systems and medical liquid oxygen (LOX) systems. This vital knowledge transfer is a key milestone in building the technical capacity of local engineers and sets a gold standard for sustainable deployment and management of medical oxygen systems across the country.
We also recognise and celebrate the visionary leadership of Dr. Daniel Kotei, Founder and CEO of Faryond Limited, whose unwavering commitment to healthcare innovation continues to reshape the oxygen infrastructure landscape across Africa.
Dr. Kotei’s instrumental role in the U.S. Government-funded medical liquid oxygen project benefiting ten hospitals across Ghana demonstrates his leadership in delivering transformative, high-impact solutions that improve lives.
A special thanks goes to Mr. Joseph Ofori for leading comprehensive technical training on Ambra Sistemi’s Mini Criotel and its advanced remote monitoring platform.
This system empowers engineers, hospital administrators, and government stakeholders with real-time oversight of liquid oxygen consumption across facilities nationwide. It supports the integration of both existing and new oxygen plants, enabling efficient monitoring, budgeting, maintenance, and overall sustainability of medical oxygen supply.
What’s even more remarkable is Ambra Sistemi’s additional innovation, a device that monitors the purity level of oxygen within gas pipeline systems, also integrated into the Ambra remote monitoring platform.
This feature gives health authorities, including the Ministry of Health, the ability to remotely verify the purity of oxygen being delivered to patients in real-time across multiple hospitals. It ensures that oxygen quality is not only consistent but fully traceable, reinforcing patient safety, compliance, and trust in the national oxygen infrastructure.
As the African representative of Auguste Cryogenics, Cryonorm Group, and Ambra Sistemi, Faryond Limited is honoured to bring world-class technology, equipment, and expertise to Africa.
These partnerships are more than just collaborations; they are strategic alliances driving healthcare resilience, innovation, and sustainability on the continent.
Together, we are not only building systems, we are laying the foundation for a healthier, self-reliant, and more sustainable future for Africa.
PHOTO: From left Mr. Joseph Ofori (Managing Director, Faryond Ltd), Mr. Roman Zdechovan (Technical Director, Auguste Cryogenics), Dr. Daniel Kotei (Chief Executive Officer, Faryond Ltd), Mr. Rastislav Majerníček (Quality Control Manager, Auguste Cryogenic
